Drug Trial Radar · NCT06949800
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Sep 4, 2026
Primary completion
Oct 31, 2027
Study completion May 31, 2028
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Exegi Pharma, LLC; National Cancer Institute (NCI)
- First posted
- Apr 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population
Conditions
- HSIL, High Grade Squamous Intraepithelial Lesion
- HPV-Related Squamous Cell Carcinoma
- Anal HSIL
Interventions
EXE-346 ProbioticDrug
Given as a single-dose, powder packet to mix with water
PlaceboDrug
Given as a single-dose, powder packet to mix with water
Usual Care High Resolution Anoscopy (HRA)Procedure
Non-investigational HRA will be performed
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with no disease presentTime frame: Up to 36 weeks
- Proportion of participants reporting treatment-emergent adverse eventsTime frame: Up to 36 weeks
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
University of California, San Francisco
San Francisco, California · Recruiting
University of Puerto Rico Comprehensive Cancer Center
San Juan, Puerto Rico, Puerto Rico · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.